Sign in
Explore the registryTrack Palazestrant's trials

OPERA-02

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

PalazestrantOngoingRecruitingPhase 3Open NCT07085767 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…